← Evidence map

ArticleThe lancet. Healthy longevity2024

SGLT2 inhibitors and GLP-1 receptor agonists: which is the best anti-frailty drug?

Pasquale Mone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

7 papers cite it

2024
2025
2026
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 39284335